Index of reports
> Cases with Osteomyelitis (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fareston (Toremifene) where reactions include osteomyelitis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Fareston side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-10
Patient: female, weighing 76.0 kg (167.2 pounds)
Reactions: Primary Sequestrum, Gingivitis, Respiratory Disorder, Exposed Bone in JAW, Bone Pain, Neoplasm Progression, Osteomyelitis, Bone Fistula, Periodontal Infection, Pleural Effusion, Pneumonia Staphylococcal, Metastases To Chest Wall, Bone Lesion, General Physical Health Deterioration, Bone Swelling, Mediastinal Shift, Neoplasm Malignant, Osteonecrosis of JAW, Bone Neoplasm, Gingival Infection, Metastases To Bone
Adverse event resulted in: death
Drug(s) suspected as cause:
Aredia
Dosage: 90 mg, daily
Indication: Metastases To Bone
Start date: 2006-02-01
End date: 2006-05-01
Fareston
Dosage: 40 mg, daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2009-07-27
End date: 2010-11-22
Femara
Dosage: 2.5 mg, daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-11-22
End date: 2011-04-25
Medroxyprogesterone Acetate
Dosage: 1200 mg, daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2008-06-02
End date: 2009-07-27
Tamoxifen Citrate
Dosage: 20 mg, daily
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-04-25
End date: 2011-09-13
Zometa
Dosage: 4 mg, daily
Indication: Metastases To Bone
Start date: 2006-05-01
End date: 2008-05-01
Other drugs received by patient: Capecitabine; Paclitaxel; Medroxyprogesterone Acetate
|